Cargando…
SREBP2 is upregulated in esophageal squamous cell carcinoma and co-operates with c-Myc to regulate HMGCR expression
Dysregulations of the mevalonate pathway (MVA) have been previously identified. Our previous study demonstrated that 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), the rate-limiting enzyme of the MVA pathway, was upregulated in esophageal squamous cell carcinoma (ESCC) and statin-inhibited...
Autores principales: | Zhong, Chenxi, Fan, Limin, Li, Zhigang, Yao, Feng, Zhao, Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755167/ https://www.ncbi.nlm.nih.gov/pubmed/31432128 http://dx.doi.org/10.3892/mmr.2019.10577 |
Ejemplares similares
-
AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver
por: Liu, Shudong, et al.
Publicado: (2015) -
The interaction between polyphyllin I and SQLE protein induces hepatotoxicity through SREBP-2/HMGCR/SQLE/LSS pathway
por: Li, Zhiqi, et al.
Publicado: (2023) -
Hypolipidemic properties of Chlorella pyrenoidosa organic acids via AMPK/HMGCR/SREBP‐1c pathway in vivo
por: Chen, Jie, et al.
Publicado: (2020) -
PRL-1 overexpressed placenta-derived mesenchymal stem cells suppress adipogenesis in Graves’ ophthalmopathy through SREBP2/HMGCR pathway
por: Park, Mira, et al.
Publicado: (2021) -
Anti-HMGCR Myopathy
por: Mohassel, Payam, et al.
Publicado: (2018)